Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 4
1991 3
1992 3
1993 9
1994 2
1995 9
1996 9
1997 10
1998 10
1999 10
2000 10
2001 5
2002 5
2003 10
2004 22
2005 18
2006 18
2007 20
2008 18
2009 21
2010 26
2011 24
2012 21
2013 25
2014 38
2015 30
2016 27
2017 37
2018 29
2019 30
2020 43
2021 41
2022 35
Text availability
Article attribute
Article type
Publication date

Search Results

540 results
Results by year
Filters applied: . Clear all
Page 1
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
Sadik A, Somarribas Patterson LF, Öztürk S, Mohapatra SR, Panitz V, Secker PF, Pfänder P, Loth S, Salem H, Prentzell MT, Berdel B, Iskar M, Faessler E, Reuter F, Kirst I, Kalter V, Foerster KI, Jäger E, Guevara CR, Sobeh M, Hielscher T, Poschet G, Reinhardt A, Hassel JC, Zapatka M, Hahn U, von Deimling A, Hopf C, Schlichting R, Escher BI, Burhenne J, Haefeli WE, Ishaque N, Böhme A, Schäuble S, Thedieck K, Trump S, Seiffert M, Opitz CA. Sadik A, et al. Among authors: haefeli we. Cell. 2020 Sep 3;182(5):1252-1270.e34. doi: 10.1016/j.cell.2020.07.038. Epub 2020 Aug 19. Cell. 2020. PMID: 32818467 Free article.
Drug-Drug Interactions with Direct Oral Anticoagulants.
Foerster KI, Hermann S, Mikus G, Haefeli WE. Foerster KI, et al. Among authors: haefeli we. Clin Pharmacokinet. 2020 Aug;59(8):967-980. doi: 10.1007/s40262-020-00879-x. Clin Pharmacokinet. 2020. PMID: 32157630 Free PMC article. Review.
[Tablet splitting].
Quinzler R, Haefeli WE. Quinzler R, et al. Among authors: haefeli we. Ther Umsch. 2006 Jun;63(6):441-7. doi: 10.1024/0040-5930.63.6.441. Ther Umsch. 2006. PMID: 16841582 Review. German.
[Good prescribing practice].
Seidling HM, Haefeli WE. Seidling HM, et al. Among authors: haefeli we. Ther Umsch. 2014 Jun;71(6):313-6. doi: 10.1024/0040-5930/a000518. Ther Umsch. 2014. PMID: 24867345 Review. German.
[Drug interactions].
Hafner V, Grün B, Markert C, Czock D, Mikus G, Haefeli WE. Hafner V, et al. Among authors: haefeli we. Internist (Berl). 2010 Mar;51(3):359-69; quiz 370. doi: 10.1007/s00108-009-2553-1. Internist (Berl). 2010. PMID: 20127303 German.
Oral Drugs Against COVID-19.
Mikus G, Foerster KI, Terstegen T, Vogt C, Said A, Schulz M, Haefeli WE. Mikus G, et al. Among authors: haefeli we. Dtsch Arztebl Int. 2022 Apr 15;119(15):263-269. doi: 10.3238/arztebl.m2022.0152. Dtsch Arztebl Int. 2022. PMID: 35302484 Free PMC article.
[Electronic decision support to promote medication safety].
Haefeli WE, Seidling HM. Haefeli WE, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Mar;61(3):271-277. doi: 10.1007/s00103-017-2685-8. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018. PMID: 29340732 Review. German.
Haunting medicines.
Schuerch LV, Nyfeler J, Holder G, Surber C, Haefeli WE. Schuerch LV, et al. Among authors: haefeli we. Am J Health Syst Pharm. 1997 Oct 15;54(20):2403. doi: 10.1093/ajhp/54.20.2403. Am J Health Syst Pharm. 1997. PMID: 9347104 No abstract available.
Medication safety through e-health technology: can we close the gaps?
Seidling HM, Kaltschmidt J, Ammenwerth E, Haefeli WE. Seidling HM, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2013 Sep;76 Suppl 1(Suppl 1):i-iv. doi: 10.1111/bcp.12217. Br J Clin Pharmacol. 2013. PMID: 24007455 Free PMC article. No abstract available.
540 results